UKIPO dismisses Swiss IP office’s bid to stop Indian pharma TM
19-11-2019
ratlos / Shutterstock.com
The UK Intellectual Property Office (IPO) has today, July 5, opened a consultation into supplementary protection certificate (SPC) law in the event of a ‘no deal’ Brexit.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
UKIPO, Brexit, European Commission, supplementary protection certificate, SPC manufacturing waiver, pharmaceuticals, biosimilars
